lexiscan
Generic: regadenoson
Labeler: astellas pharma us, inc.Drug Facts
Product Profile
Brand Name
lexiscan
Generic Name
regadenoson
Labeler
astellas pharma us, inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
regadenoson .08 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0469-6501
Product ID
0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA022161
Listing Expiration
2026-12-31
Marketing Start
2008-04-10
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
04696501
Hyphenated Format
0469-6501
Supplemental Identifiers
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lexiscan (source: ndc)
Generic Name
regadenoson (source: ndc)
Application Number
NDA022161 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .08 mg/mL
Packaging
- 5 mL in 1 SYRINGE, PLASTIC (0469-6501-89)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "8fb5b92b-3654-43ff-98d3-3ac23c9a0b10", "openfda": {"nui": ["N0000178375", "N0000175788"], "unii": ["2XLN4Y044H"], "spl_set_id": ["057289f4-2e18-4c1e-bed4-6c1858e2ef16"], "pharm_class_epc": ["Adenosine Receptor Agonist [EPC]"], "pharm_class_moa": ["Adenosine Receptor Agonists [MoA]"], "manufacturer_name": ["Astellas Pharma US, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 mL in 1 SYRINGE, PLASTIC (0469-6501-89)", "package_ndc": "0469-6501-89", "marketing_start_date": "20080410"}], "brand_name": "LEXISCAN", "product_id": "0469-6501_8fb5b92b-3654-43ff-98d3-3ac23c9a0b10", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adenosine Receptor Agonist [EPC]", "Adenosine Receptor Agonists [MoA]"], "product_ndc": "0469-6501", "generic_name": "regadenoson", "labeler_name": "Astellas Pharma US, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LEXISCAN", "active_ingredients": [{"name": "REGADENOSON", "strength": ".08 mg/mL"}], "application_number": "NDA022161", "marketing_category": "NDA", "marketing_start_date": "20080410", "listing_expiration_date": "20261231"}